Market Overview

Puration Unveils Plans For Cannabis Cultivation Deal With Kali-Extracts' NCM Biotech

Share:
Puration Unveils Plans For Cannabis Cultivation Deal With Kali-Extracts' NCM Biotech

Cannabis company Puration Inc. (OTCPK: PURAannouned Friday the sale of its cultivation business.

The Dallas-based company had previously spun-off the segment in a deal with Nouveau (OTC: NOUV), in exchange for common stock. That deal has been canceled.

Instead, Puration has opted to merge the cultivation business with NCM Biotech, a subsidiary of Kali-Extracts (OTCPK: KALY).

NCM Biotech specializes in the research and the development of treatments derived from its patented cannabis extraction process.

The common stock will be issued to Puration's shareholders in a dividend distribution at a ratio one-for-one.

In January, Puration and Kali-Extracts started negotiations about a prospective purchase of Kali-Extracts' CBD confection assets.

Two months later, Puration confirmed that the acquisition was underway.

Meanwhile, driven by estimations that the CBD pet products market in the U.S. could reach $1.16 billion over the next two years, Puration has made an offer to purchase an unspecified CBD pet products operation earlier this year.

Courtesy photo

 

Related Articles (PURA)

View Comments and Join the Discussion!

Posted-In: cannabis industry cannabis salesCannabis M&A News

Cannabis Movers